Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer

Abstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We d...

Full description

Bibliographic Details
Main Authors: Boju Pan, Yuxin Kang, Yan Jin, Lin Yang, Yushuang Zheng, Lei Cui, Jian Sun, Jun Feng, Yuan Li, Lingchuan Guo, Zhiyong Liang
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Translational Medicine
Subjects:
TPS
Online Access:https://doi.org/10.1186/s12967-021-02898-z
id doaj-ba7f4e0e141342db950244bc4f0c4799
record_format Article
spelling doaj-ba7f4e0e141342db950244bc4f0c47992021-06-13T11:13:55ZengBMCJournal of Translational Medicine1479-58762021-06-0119111210.1186/s12967-021-02898-zAutomated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancerBoju Pan0Yuxin Kang1Yan Jin2Lin Yang3Yushuang Zheng4Lei Cui5Jian Sun6Jun Feng7Yuan Li8Lingchuan Guo9Zhiyong Liang10Department of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeSchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Fudan University Shanghai Cancer CenterSchool of Engineering, Westlake UniversityDepartment of Pathology, the First Affiliated Hospital of Soochow UniversitySchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeSchool of Information Science and Technology, Northwest UniversityDepartment of Pathology, Fudan University Shanghai Cancer CenterDepartment of Pathology, the First Affiliated Hospital of Soochow UniversityDepartment of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We developed a novel automated tumor proportion scoring (TPS) algorithm, and evaluated the concordance of this image analysis algorithm with pathologist scores. Methods We included 230 NSCLC samples prepared and stained using the PD-L1(SP263) and PD-L1(22C3) antibodies separately. The scoring algorithm was based on regional segmentation and cellular detection. We used 30 PD-L1(SP263) slides for algorithm training and validation. Results Overall, 192 SP263 samples and 117 22C3 samples were amenable to image analysis scoring. Automated image analysis and pathologist scores were highly concordant [intraclass correlation coefficient (ICC) = 0.873 and 0.737]. Concordances at moderate and high cutoff values were better than at low cutoff values significantly. For SP263 and 22C3, the concordances in squamous cell carcinomas were better than adenocarcinomas (SP263 ICC = 0.884 vs 0.783; 22C3 ICC = 0.782 vs 0.500). In addition, our automated immune cell proportion scoring (IPS) scores achieved high positive correlation with the pathologists TPS scores. Conclusions The novel automated image analysis scoring algorithm permitted quantitative comparison with existing PD-L1 diagnostic assays and demonstrated effectiveness by combining cellular and regional information for image algorithm training. Meanwhile, the fact that concordances vary in different subtypes of NSCLC samples, which should be considered in algorithm development.https://doi.org/10.1186/s12967-021-02898-zPD-L1NSCLCAutomated scoringTPSMultistage ensemble strategy
collection DOAJ
language English
format Article
sources DOAJ
author Boju Pan
Yuxin Kang
Yan Jin
Lin Yang
Yushuang Zheng
Lei Cui
Jian Sun
Jun Feng
Yuan Li
Lingchuan Guo
Zhiyong Liang
spellingShingle Boju Pan
Yuxin Kang
Yan Jin
Lin Yang
Yushuang Zheng
Lei Cui
Jian Sun
Jun Feng
Yuan Li
Lingchuan Guo
Zhiyong Liang
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
Journal of Translational Medicine
PD-L1
NSCLC
Automated scoring
TPS
Multistage ensemble strategy
author_facet Boju Pan
Yuxin Kang
Yan Jin
Lin Yang
Yushuang Zheng
Lei Cui
Jian Sun
Jun Feng
Yuan Li
Lingchuan Guo
Zhiyong Liang
author_sort Boju Pan
title Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
title_short Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
title_full Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
title_fullStr Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
title_full_unstemmed Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
title_sort automated tumor proportion scoring for pd-l1 expression based on multistage ensemble strategy in non-small cell lung cancer
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2021-06-01
description Abstract Introduction Programmed cell death ligand-1 (PD-L1) expression is a promising biomarker for identifying treatment related to non-small cell lung cancer (NSCLC). Automated image analysis served as an aided PD-L1 scoring tool for pathologists to reduce inter- and intrareader variability. We developed a novel automated tumor proportion scoring (TPS) algorithm, and evaluated the concordance of this image analysis algorithm with pathologist scores. Methods We included 230 NSCLC samples prepared and stained using the PD-L1(SP263) and PD-L1(22C3) antibodies separately. The scoring algorithm was based on regional segmentation and cellular detection. We used 30 PD-L1(SP263) slides for algorithm training and validation. Results Overall, 192 SP263 samples and 117 22C3 samples were amenable to image analysis scoring. Automated image analysis and pathologist scores were highly concordant [intraclass correlation coefficient (ICC) = 0.873 and 0.737]. Concordances at moderate and high cutoff values were better than at low cutoff values significantly. For SP263 and 22C3, the concordances in squamous cell carcinomas were better than adenocarcinomas (SP263 ICC = 0.884 vs 0.783; 22C3 ICC = 0.782 vs 0.500). In addition, our automated immune cell proportion scoring (IPS) scores achieved high positive correlation with the pathologists TPS scores. Conclusions The novel automated image analysis scoring algorithm permitted quantitative comparison with existing PD-L1 diagnostic assays and demonstrated effectiveness by combining cellular and regional information for image algorithm training. Meanwhile, the fact that concordances vary in different subtypes of NSCLC samples, which should be considered in algorithm development.
topic PD-L1
NSCLC
Automated scoring
TPS
Multistage ensemble strategy
url https://doi.org/10.1186/s12967-021-02898-z
work_keys_str_mv AT bojupan automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT yuxinkang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT yanjin automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT linyang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT yushuangzheng automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT leicui automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT jiansun automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT junfeng automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT yuanli automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT lingchuanguo automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
AT zhiyongliang automatedtumorproportionscoringforpdl1expressionbasedonmultistageensemblestrategyinnonsmallcelllungcancer
_version_ 1721380055272128512